NO20014896L - Injiserbare naltrexonmikrosfaerepreparater og deres anvendelse ved redusering av heroin- og alkoholforbruk - Google Patents

Injiserbare naltrexonmikrosfaerepreparater og deres anvendelse ved redusering av heroin- og alkoholforbruk

Info

Publication number
NO20014896L
NO20014896L NO20014896A NO20014896A NO20014896L NO 20014896 L NO20014896 L NO 20014896L NO 20014896 A NO20014896 A NO 20014896A NO 20014896 A NO20014896 A NO 20014896A NO 20014896 L NO20014896 L NO 20014896L
Authority
NO
Norway
Prior art keywords
alcohol consumption
naltrexone
heroin
microsphere preparations
reducing
Prior art date
Application number
NO20014896A
Other languages
English (en)
Other versions
NO328647B1 (no
NO20014896D0 (no
Inventor
Thomas R Tice
Jay K Staas
Teresa M Ferrell
Original Assignee
Southern Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southern Res Inst filed Critical Southern Res Inst
Publication of NO20014896D0 publication Critical patent/NO20014896D0/no
Publication of NO20014896L publication Critical patent/NO20014896L/no
Publication of NO328647B1 publication Critical patent/NO328647B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20014896A 1999-04-09 2001-10-08 Injiserbare naltrexonmikrosfaerepreparater og deres anvendelse ved redusering av heroin- og alkoholforbruk NO328647B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12847799P 1999-04-09 1999-04-09
PCT/US2000/009438 WO2000061147A1 (en) 1999-04-09 2000-04-08 Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol

Publications (3)

Publication Number Publication Date
NO20014896D0 NO20014896D0 (no) 2001-10-08
NO20014896L true NO20014896L (no) 2001-12-07
NO328647B1 NO328647B1 (no) 2010-04-19

Family

ID=22435553

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014896A NO328647B1 (no) 1999-04-09 2001-10-08 Injiserbare naltrexonmikrosfaerepreparater og deres anvendelse ved redusering av heroin- og alkoholforbruk

Country Status (25)

Country Link
US (1) US6306425B1 (no)
EP (1) EP1171132B1 (no)
JP (2) JP4995371B2 (no)
KR (1) KR100621261B1 (no)
CN (1) CN1210031C (no)
AT (1) ATE262906T1 (no)
AU (1) AU780852B2 (no)
BR (1) BR0009639A (no)
CA (1) CA2369302C (no)
CZ (1) CZ20013636A3 (no)
DE (1) DE60009477T2 (no)
DK (1) DK1171132T3 (no)
EA (1) EA004734B1 (no)
ES (1) ES2218147T3 (no)
HK (1) HK1047245B (no)
HU (1) HUP0200838A3 (no)
IL (2) IL145802A0 (no)
MX (1) MXPA01010185A (no)
NO (1) NO328647B1 (no)
NZ (1) NZ515359A (no)
PL (1) PL196930B1 (no)
PT (1) PT1171132E (no)
TR (1) TR200102880T2 (no)
UA (1) UA79921C2 (no)
WO (1) WO2000061147A1 (no)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194006B1 (en) * 1998-12-30 2001-02-27 Alkermes Controlled Therapeutics Inc. Ii Preparation of microparticles having a selected release profile
US6610317B2 (en) 1999-05-27 2003-08-26 Acusphere, Inc. Porous paclitaxel matrices and methods of manufacture thereof
US7919119B2 (en) 1999-05-27 2011-04-05 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
WO2001056635A1 (de) * 2000-02-01 2001-08-09 Disetronic Licensing Ag Behälter und vorrichtung zur verabreichung einer substanz
US6264987B1 (en) * 2000-05-19 2001-07-24 Alkermes Controlled Therapeutics Inc. Ii Method for preparing microparticles having a selected polymer molecular weight
US6495164B1 (en) * 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
CN1268338C (zh) 2001-07-06 2006-08-09 恩德制药公司 用作止痛剂的6－羟基羟吗啡酮的口服给药
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
ATE376832T1 (de) 2001-07-06 2007-11-15 Penwest Pharmaceuticals Co Verzögert freisetzende formulierungen von oxymorphon
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7157102B1 (en) 2002-05-31 2007-01-02 Biotek, Inc. Multi-layered microcapsules and method of preparing same
US7041320B1 (en) 2002-05-31 2006-05-09 Biotek, Inc. High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
US6972291B2 (en) * 2002-07-02 2005-12-06 Bernstein Richard K Method for reducing food intake
US7842377B2 (en) * 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US20040109886A1 (en) * 2002-08-27 2004-06-10 Larry Rigby Methods and apparatus for transdermal delivery of abusable drugs with a deterrent agent
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
EP1610674A4 (en) * 2003-03-13 2008-05-21 Cheryl M Burgess METHODS OF ADMINISTERING MATERIAL TO PATIENT TO OBTAIN DERMAL IMPROVEMENT
AU2004245057B2 (en) * 2003-06-04 2008-07-31 Alkermes Pharma Ireland Limited Polymorphic forms of naltrexone
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
US20050031713A1 (en) * 2003-08-06 2005-02-10 Elliot Ehrich Methods for administering active agents to CYP3A4 sensitive patients
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
BRPI0414907A (pt) * 2003-09-30 2006-11-07 Acusphere Inc formulações farmacêuticas com liberação sustentada injetáveis, orais ou tópicas
US7901770B2 (en) 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
ATE426399T1 (de) * 2004-02-23 2009-04-15 Euro Celtique Sa Missbrauchsichere transdermale abgabevorrichtung fur opioide, enthaltend opioidantagonist in form von mikrokugelchen
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US20050245461A1 (en) * 2004-03-19 2005-11-03 Elliot Ehrich Methods for treating alcoholism
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US7919499B2 (en) * 2004-04-22 2011-04-05 Alkermes, Inc. Naltrexone long acting formulations and methods of use
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
CN1872063B (zh) * 2005-06-03 2011-01-26 中国人民解放军军事医学科学院毒物药物研究所 纳美芬或其盐的长效注射用微球或组合物及其制备方法
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
EP1810714A1 (de) * 2006-01-19 2007-07-25 Holger Lars Hermann Verwendung einer Kombination von Heroin und Naloxon zur Drogensubstitution
US8883817B2 (en) * 2007-10-18 2014-11-11 Aiko Biotechnology Combination analgesic employing opioid and neutral antagonist
US8748448B2 (en) 2007-10-18 2014-06-10 Aiko Biotechnology Combination analgesic employing opioid agonist and neutral antagonist
KR20100121463A (ko) 2007-12-17 2010-11-17 라보팜 인코포레이트 오용 예방적 방출 제어형 제제
JP5667575B2 (ja) 2008-12-16 2015-02-12 パラディン ラブス インコーポレーテッド 誤用を防止する放出制御製剤
US20100196436A1 (en) * 2009-01-30 2010-08-05 Gooberman Lance L Implants containing disulfiram and an anti-inflammatory agent
US8791093B2 (en) * 2009-05-29 2014-07-29 Lance L. Gooberman Pharmaceutical delivery systems for treatment of substance abuse and other addictions
EA029077B1 (ru) * 2010-03-09 2018-02-28 Алкермес Фарма Айэленд Лимитед Устойчивая к спирту фармацевтическая лекарственная форма
RU2476209C1 (ru) * 2012-02-29 2013-02-27 Станислав Анатольевич Кедик Имплантируемое лекарственное средство на основе налтрексона для лечения пациентов, зависимых от алкоголя или опиатов
BR112016002342A8 (pt) 2013-08-06 2018-01-23 Dong Kook Pharm Co Ltd microesfera entecavir, método para preparação de uma microesfera entecavir, e, composição farmacêutica
WO2016013993A1 (en) * 2014-07-25 2016-01-28 Imuneks Farma Llac Sanayi Ve Ticaret A.Ş. Stable preservative free ophthalmic formulations of opioid antagonists
AU2019362730B2 (en) 2018-10-15 2022-10-20 Chong Kun Dang Pharmaceutical Corp. Injectable long-acting naltrexone microparticle compositions
GR1009871B (el) * 2019-07-30 2020-11-12 Φαρματεν Α.Β.Ε.Ε. Φαρμακευτικο σκευασμα που περιλαμβανει μικροσφαιριδια ναλτρεξονης και μεθοδος παρασκευης αυτου
US20210059943A1 (en) * 2019-09-04 2021-03-04 Buffalo Pacific LLC Systems and methods addressing multiple aspects to provide a comprehensive recovery program for addictions, chronic conditions and diseases
AU2022232414A1 (en) * 2021-03-09 2023-08-17 Inventage Lab Inc. Sustained formulation for prevention or treatment of autoimmune disease containing naltrexone and method using same
AU2022394933A1 (en) * 2021-11-18 2024-05-09 Inventage Lab Inc. Sustained-release injectable composition containing naltrexone and method for preparing same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887699A (en) 1969-03-24 1975-06-03 Seymour Yolles Biodegradable polymeric article for dispensing drugs
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4623588A (en) 1984-02-06 1986-11-18 Biotek, Inc. Controlled release composite core coated microparticles
US4568559A (en) 1984-02-06 1986-02-04 Biotek, Inc. Composite core coated microparticles and process of preparing same
US4981696A (en) 1986-12-22 1991-01-01 E. I. Du Pont De Nemours And Company Polylactide compositions
DE3710175A1 (de) 1987-02-12 1988-08-25 Hoechst Ag Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung
FR2618674B1 (fr) 1987-07-30 1990-06-15 Ire Celltarg Sa Microparticules comportant un polymere biodegradable controlant la liberation d'un principe actif antimalarique, compositions pharmaceutiques en comprenant et procede de preparation
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
DE3734223A1 (de) * 1987-10-09 1989-04-20 Boehringer Ingelheim Kg Implantierbares, biologisch abbaubares wirkstofffreigabesystem
JP2670680B2 (ja) 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法
US4902515A (en) * 1988-04-28 1990-02-20 E. I. Dupont De Nemours And Company Polylactide compositions
ATE133087T1 (de) 1989-05-04 1996-02-15 Southern Res Inst Einkapselungsverfahren
US5486362A (en) * 1991-05-07 1996-01-23 Dynagen, Inc. Controlled, sustained release delivery system for treating drug dependency
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
CA2290788A1 (en) * 1997-05-20 1998-11-26 Suchitra Krishnan-Sarin Substance dependence treatment using opiate antagonists and serotonin compounds
JPH11269094A (ja) * 1998-01-16 1999-10-05 Takeda Chem Ind Ltd 徐放性組成物、その製造法および用途

Also Published As

Publication number Publication date
UA79921C2 (en) 2007-08-10
CZ20013636A3 (cs) 2002-03-13
ATE262906T1 (de) 2004-04-15
HUP0200838A3 (en) 2005-07-28
EA200101062A1 (ru) 2002-04-25
EP1171132B1 (en) 2004-03-31
BR0009639A (pt) 2002-02-05
CN1354664A (zh) 2002-06-19
NO328647B1 (no) 2010-04-19
US6306425B1 (en) 2001-10-23
PL196930B1 (pl) 2008-02-29
PT1171132E (pt) 2004-07-30
DE60009477D1 (de) 2004-05-06
KR20020011975A (ko) 2002-02-09
MXPA01010185A (es) 2003-07-21
HK1047245B (zh) 2006-03-03
JP2002541202A (ja) 2002-12-03
WO2000061147A1 (en) 2000-10-19
NZ515359A (en) 2002-10-25
CN1210031C (zh) 2005-07-13
KR100621261B1 (ko) 2006-09-13
CA2369302C (en) 2007-09-25
IL145802A0 (en) 2002-07-25
JP4995371B2 (ja) 2012-08-08
IL145802A (en) 2009-02-11
HK1047245A1 (en) 2003-02-14
AU4220300A (en) 2000-11-14
JP2010031036A (ja) 2010-02-12
TR200102880T2 (tr) 2002-03-21
NO20014896D0 (no) 2001-10-08
DK1171132T3 (da) 2004-07-12
PL350548A1 (en) 2002-12-16
CA2369302A1 (en) 2000-10-19
AU780852B2 (en) 2005-04-21
EA004734B1 (ru) 2004-08-26
EP1171132A1 (en) 2002-01-16
DE60009477T2 (de) 2005-02-24
ES2218147T3 (es) 2004-11-16
HUP0200838A2 (hu) 2002-07-29

Similar Documents

Publication Publication Date Title
NO20014896L (no) Injiserbare naltrexonmikrosfaerepreparater og deres anvendelse ved redusering av heroin- og alkoholforbruk
NO20020924D0 (no) Injiserbare buprenorphinmikropartikkelpreparater og deres anvendelse
AU2001243686A1 (en) Injectable and swellable microspheres for dermal augmentation
AU7178498A (en) Prefillable syringes, plungers and injectors for use therewith
AU2001263996A1 (en) Prolonged release microspheres for injection delivery and preparation method
WO2001037889A3 (de) Spritzbares knochenersatzmaterial
HK1052569B (zh) 睡眠狀態轉換方法及系統
MXPA03005577A (es) Inyector de tipo pluma que tiene mecanismo de sujecion para cartucho de medicamento.
AU2001261247A1 (en) Internal combustion engine operable in pcci mode with early control injection and method of operation
WO2000011971A3 (en) Fiber and vitamin-fortified beverage
AU2001255853A1 (en) Device and process for improving fuel consumption and reducing emissions upon fuel combustion
EP1458870A4 (en) COMPOSITIONS AND METHODS USING ARNS, AMPHIPATHIC COMPOUNDS AND POLYCATIONS
AU2001269688A1 (en) Combination containing an antifolate and methylmalonic acid lowering agent
GB0115810D0 (en) Organic anti-reflective coating polymer,anti-reflective coating composition comprising the same and method of preparation thereof
Han Wounded Nationalism: The Minsaengdan Incident and Kim Il Sung in Eastern Manchuria
GB2364306B (en) Organic anti-reflective coating polymer,anti-reflective coating composition comprising the same and method of preparation thereof
EP1149860A4 (en) METHOD FOR TREATING A FLAME-RETARDANT THERMOPLAST COMPOSITION
EP1555023A3 (en) Injectable buprenorphine microparticle compositions and their use
GB2364316B (en) Organic anti-reflective coating polymer, anti-reflective coating composition and methods of preparation thereof
CN2308600Y (zh) 多功能火柴
Han The Ford Foundation and Chinese Studies, 1950-1979
WO2002002091A3 (en) Methods and compositions for the treatment of alcoholism and alcohol dependence
AU3577195A (en) Protective kit for injection needles in particular for syringes and cannulas
方佩华 et al. The effect of thyrotropin receptor antibodies on the proliferation of FRTL-5 cells and the expression of protooncogene c-fos mRNA
Fu Sixty years of museum for history of Chinese medicine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
RE Reestablishment of rights (par. 72 patents act)
MM1K Lapsed by not paying the annual fees